Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study
Early anakinra initiation within the first 3 months of SJIA onset after NSAID failure ensures long-term remission and reduces corticosteroid use. Anakinra should not be continued for more than 3 months in nonresponding children.
Authors
- Jérôme Granel (ORCID: https://orcid.org/0000-0002-4470-1023)
- Adeline Ravalet
- Johanna Clet
- Aseel Daghistani
- Olivier Richer (ORCID: https://orcid.org/0000-0002-7058-9792)
- Marion Bailhache (ORCID: https://orcid.org/0000-0002-0970-1677)
- Pascal Pillet
Institutions
- Hôpital Pellegrin (FR)
Publication Details
- Journal
- ARP Rheumatology
- Published
- 2024-12-31
- DOI
- https://doi.org/10.63032/tevi1838
- Citations
- 1
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45